These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 15869802

  • 1. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S, Singh P, Mishra V, Vyas SP.
    Immunol Lett; 2005 Oct 15; 101(1):41-9. PubMed ID: 15869802
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mannosylated niosomes as carrier adjuvant system for topical immunization.
    Jain S, Vyas SP.
    J Pharm Pharmacol; 2005 Sep 15; 57(9):1177-84. PubMed ID: 16105238
    [Abstract] [Full Text] [Related]

  • 4. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization.
    Jain S, Vyas SP.
    J Liposome Res; 2006 Sep 15; 16(4):331-45. PubMed ID: 17162576
    [Abstract] [Full Text] [Related]

  • 5. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS, Vyas SP.
    Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012
    [Abstract] [Full Text] [Related]

  • 6. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S, Rawat A, Dubey PK, Gupta PN, Khatri K, Goyal AK, Vyas SP.
    Int J Pharm; 2007 Aug 01; 340(1-2):13-9. PubMed ID: 17446015
    [Abstract] [Full Text] [Related]

  • 7. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 8. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A, Katare OP, Singh B, Vyas SP.
    Int J Pharm; 2010 Jan 29; 385(1-2):47-52. PubMed ID: 19835938
    [Abstract] [Full Text] [Related]

  • 9. PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
    Jain AK, Goyal AK, Mishra N, Vaidya B, Mangal S, Vyas SP.
    Int J Pharm; 2010 Mar 15; 387(1-2):253-62. PubMed ID: 20005936
    [Abstract] [Full Text] [Related]

  • 10. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex.
    Wang J, Hu JH, Li FQ, Liu GZ, Zhu QG, Liu JY, Ma HJ, Peng C, Si FG.
    Exp Dermatol; 2007 Sep 15; 16(9):724-9. PubMed ID: 17697144
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.
    Pandey RS, Dixit VK.
    J Drug Target; 2010 May 15; 18(4):282-91. PubMed ID: 19958131
    [Abstract] [Full Text] [Related]

  • 12. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization.
    Gupta PN, Vyas SP.
    Colloids Surf B Biointerfaces; 2011 Jan 01; 82(1):118-25. PubMed ID: 20843665
    [Abstract] [Full Text] [Related]

  • 13. Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B.
    Maheshwari C, Pandey RS, Chaurasiya A, Kumar A, Selvam DT, Prasad GB, Dixit VK.
    Int Immunopharmacol; 2011 Oct 01; 11(10):1516-22. PubMed ID: 21609785
    [Abstract] [Full Text] [Related]

  • 14. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK, Tomar P, Sharma V, Dixit VK.
    Vaccine; 2011 Nov 08; 29(48):9026-37. PubMed ID: 21939718
    [Abstract] [Full Text] [Related]

  • 15. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies.
    Sihorkar V, Vyas SP.
    Pharmazie; 2000 Feb 08; 55(2):107-13. PubMed ID: 10723768
    [Abstract] [Full Text] [Related]

  • 16. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK.
    Eur J Pharm Sci; 2008 Apr 23; 33(4-5):424-33. PubMed ID: 18359615
    [Abstract] [Full Text] [Related]

  • 17. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.
    Eur J Pharm Biopharm; 2008 Jun 23; 69(2):405-16. PubMed ID: 18364251
    [Abstract] [Full Text] [Related]

  • 18. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
    Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK.
    Vaccine; 2006 May 29; 24(22):4847-55. PubMed ID: 16600441
    [Abstract] [Full Text] [Related]

  • 19. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
    Bos GW, Kanellos T, Crommelin DJ, Hennink WE, Howard CR.
    Vaccine; 2004 Dec 09; 23(4):460-9. PubMed ID: 15530694
    [Abstract] [Full Text] [Related]

  • 20. Mannosylated liposomes for targeted vaccines delivery.
    Vyas SP, Goyal AK, Khatri K.
    Methods Mol Biol; 2010 Dec 09; 605():177-88. PubMed ID: 20072881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.